Literature DB >> 35338398

Clinical profile of 80-year-old and older thyroid eye disease patients.

Niv Levy1,2, Hana Leiba1,2, Klara Landau3, Ofira Zloto4,5, Ruth Huna-Baron6,7.   

Abstract

PURPOSE: Thyroid eye disease (TED), an autoimmune orbital disorder, follows a time-of-onset bimodal peak: 40-44 and 60-64 years for women, 45-49 and 65-69 years for men. TED, however, can also commence in old age. The study's purpose was to evaluate TED in octo- and nonagenarians.
METHODS: Medical records of 19 ≥ 80 years geriatric patients at time of diagnosis were compared to 122 TED patients, aged 20-79. A second analysis was performed after subdividing the control group into two age groups, ≤ 40 ("young group," 16 patients) and 41-79 years ("middle-aged group," 106 patients).
RESULTS: The geriatric group's mean age was 84 years (80-94), 11 males and 8 females. Mean follow-up time was 16 months. Compared to the controls, the geriatric patients smoked less (p = 0.012), were more often hypothyroid (p = 0.019), and had concurrent myasthenia gravis (p = 0.02) at time of diagnosis. Diplopia was the most common presenting symptom among the elderly (p = 0.005) and proptosis among the controls, specifically the young group (p = 0.027). Bilateral signs were more common among seniors (p = 0.049). Optic neuropathy was diagnosed in 10% of the geriatric group (2/19) and 11% of middle-aged group (12/106), all being resolved after steroids or orbital decompression. Active disease (clinical activity score (CAS) score =  > 3) was more common among the middle-aged group (p = 0.024) while the geriatric patients tended towards higher TED severity grades. Orbital decompression and eyelid repositioning surgeries were more common among the middle-aged group. Strabismus surgeries were more common among seniors.
CONCLUSIONS: TED among octo- and nonagenarians has unique patterns, with different demographic features, more exposed to diplopia, hypothyroidism, association with myasthenia gravis, and bilateral involvement. Special attention should be given when medically managing this subgroup.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bilateral involvement; CAS score; Diplopia; GO severity; Geriatric; Thyroid eye disease (TED)

Mesh:

Year:  2022        PMID: 35338398     DOI: 10.1007/s00417-022-05627-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  19 in total

1.  Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype.

Authors:  N Manji; J D Carr-Smith; K Boelaert; A Allahabadia; M Armitage; V K Chatterjee; J H Lazarus; S H S Pearce; B Vaidya; S C Gough; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

Review 2.  Preoperative assessment of the older patient: a narrative review.

Authors:  Lawrence B Oresanya; William L Lyons; Emily Finlayson
Journal:  JAMA       Date:  2014-05       Impact factor: 56.272

Review 3.  Thyroid disease in older people.

Authors:  Panayota Mitrou; Sotirios A Raptis; George Dimitriadis
Journal:  Maturitas       Date:  2011-06-29       Impact factor: 4.342

4.  Geriatric patients are predisposed to strabismus following thyroid-related orbital decompression surgery: A multivariate analysis.

Authors:  Chris Y Wu; Alon Kahana
Journal:  Orbit       Date:  2017-02-14

5.  PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.

Authors:  Petros Perros; Miloš Žarković; Claudio Azzolini; Göksun Ayvaz; Lelio Baldeschi; Luigi Bartalena; Antonella Boschi; Claire Bournaud; Thomas Heiberg Brix; Danila Covelli; Slavica Ćirić; Chantal Daumerie; Anja Eckstein; Nicole Fichter; Dagmar Führer; Laszlo Hegedüs; George J Kahaly; Onur Konuk; Jürg Lareida; John Lazarus; Marenza Leo; Lemonia Mathiopoulou; Francesca Menconi; Daniel Morris; Onyebuchi Okosieme; Jaques Orgiazzi; Susanne Pitz; Mario Salvi; Cristina Vardanian-Vartin; Wilmar Wiersinga; Martine Bernard; Lucy Clarke; Nicola Currò; Colin Dayan; Jane Dickinson; Miroslav Knežević; Carol Lane; Claudio Marcocci; Michele Marinò; Lars Möller; Marco Nardi; Christopher Neoh; Simon Pearce; George von Arx; Fosun Baloş Törüner
Journal:  Br J Ophthalmol       Date:  2015-05-07       Impact factor: 4.638

Review 6.  Thyroid dysfunction in the elderly.

Authors:  Kristien Boelaert
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

7.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

8.  The initial clinical characteristics of Graves' orbitopathy vary with age and sex.

Authors:  D L Kendler; J Lippa; J Rootman
Journal:  Arch Ophthalmol       Date:  1993-02

9.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

10.  Geriatric thyroidology: An update.

Authors:  T P Ajish; R V Jayakumar
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.